论文部分内容阅读
目的从患者用药的安全性与依从性两个方面探讨新型药学服务模式的价值。方法 40例取药患者仍延用常规的药学服务模式,另外40例则应用新型药学服务模式,分别设为对照组与实验组,记录两组的药品差错事件及不良反应的发生情况。结果实验组无药品差错事件发生,3例(7.5%)发生不良反应,36例(90.0%)完全依从;对照组6例(15.0%)发生药品差错事件,11例(27.5%)发生不良反应,25例(62.5%)完全依从,组间比较差异有统计学意义(P<0.05)。结论新型药学服务模式的可行性高,值得临床积极开展。
Objective To explore the value of the new pharmacy service model from two aspects of the safety and compliance of patients’ medication. Methods Forty cases of patients taking drugs were still using conventional pharmacy service mode, and the other 40 cases were using new pharmacy service model, which were set as control group and experimental group respectively, the two groups of drug error events and adverse reactions were recorded. Results In the experimental group, no drug error occurred. Three patients (7.5%) had adverse reactions and 36 patients (90.0%) were completely compliant. Six patients (15.0%) in the control group experienced drug error events and 11 patients (27.5%) had adverse reactions , 25 cases (62.5%) completely complied with the difference between the two groups was statistically significant (P <0.05). Conclusion The feasibility of the new pharmacy service model is high and deserves clinical active development.